55
ALZHEON, INC. raises $78.8M under Reg D
Company raise · Raising · Offering $500M · Sold $78.8M · FRAMINGHAM, MA · filed 2026-09-10
35
ALZHEON, INC. files Form D
Company raise update · Closed · FRAMINGHAM, MA · Form D/A filed 2025-01-02
$50M+ raise
How this compares
- Among 439 fund launches filed from MA in the same window it is larger than 83%; the MA median is $2M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
Alzheon on EDGAR
Earlier and related filings by the same issuer and sponsor.
35
ALZHEON, INC. files Form D
Company raise update · Raising · Offering $150M · Sold $126.3M · FRAMINGHAM, MA · filed 2025-02-10
People on the filing
| Christopher Noel Dunn | Director |
| Neil W. Flanzraich | Director |
| Diane K. Jorkasky, M.D. | Director |
| Glenn E. Pauly | Executive Officer |
| Adem E. Albayrak | Executive Officer |
| Kenneth A. Mace | Executive Officer |
| Muneer E. Sateer | Director |
| Aidan K. Power, MRCPsych | Executive Officer |
| John K. Hey, Ph.D. | Executive Officer |
| Jordan W. Heller | Director |
| Susan K. Abushakra, M.D. | Executive Officer |
| Gino K. Santini | Director |
| Martin Tolar, M.D., Ph.D. | Executive Officer, Director |
Signed by Martin Tolar, M.D., Ph.D., President and Chief Executive Officer.
Why now — by persona
Relevant to: B2B software & services sales.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.